pricing

News

Health secretary hints at 'constructive' talks over CF drugs

Health secretary Matt Hancock has offered hope to thousands of people in the UK who have been denied access to powerful cystic fibrosis drugs because of a row over pricing with manufacturer

Views & Analysis

Market access roundup: Government grillings for Vertex and U...

It was a month characterised by governments butting heads with pharma over pricing both in the UK and across the pond.

News

UK politicians to grill Vertex CEO over CF price drug row

The CEO of Vertex Pharmaceuticals is to give evidence before influential UK politicians on Thursday, who are investigating the ongoing row over the price of cystic fibrosis drugs in England

News

Catalyst defends huge US price hike for rare disease drug

Catalyst Pharmaceuticals has defended hiking the price of the rare disease drug Firdapse (amifampridine) from virtually nothing to more than $300,000 per year following criticism from Senat

News

Catalyst sparks price row in US with $300,000 rare disease d...

The controversy over rising drug prices in the US has been reignited after it emerged that the yearly cost of the life-sustaining rare disease drug Firdapse has been hiked from free to more

News

Novartis and Lilly CEOs back Trump plans to cut drug prices

CEOs from Novartis and Eli Lilly have backed US government proposals to cut out “middlemen” in the health system, who have inflated the costs of their medicines.

Health secretary hints at 'constructive' talks over CF drugs

Market access roundup: Government grillings for Vertex and U...

UK politicians to grill Vertex CEO over CF price drug row

Catalyst defends huge US price hike for rare disease drug

Catalyst sparks price row in US with $300,000 rare disease d...

Novartis and Lilly CEOs back Trump plans to cut drug prices

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

pricing

Editor's Picks